THE EFFECT OF TEZEPELUMAB ON EXACERBATIONS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA ACCORDING TO BASELINE INHALED CORTICOSTEROID DOSE: RESULTS FROM THE PHASE 2B PATHWAY STUDY

被引：0
|
作者：
Corren, Jonathan
Ambrose, Christopher
Salapa, Kinga
Parnes, Jane
Colice, Gene
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.070
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：30A / 31A
页数：2
相关论文
共 50 条
  • [31] Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial
    Corren, Jonathan
    Parnes, Jane R.
    Wang, Liangwei
    Mo, May
    Roseti, Stephanie L.
    Griffiths, Janet M.
    O'Quinn, Sean
    van der Merwe, Rene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB80 - AB80
  • [32] Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults With Severe Asthma: Results From the DESTINATION Study
    Menzies-Gow, A.
    Wechsler, M. E.
    Brightling, C. E.
    Korn, S.
    Israel, E.
    Bednarczyk, A.
    Ponnarambil, S.
    Caveney, S.
    Almqvist, G.
    Cook, B.
    Martin, N.
    Kotalik, A.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
    Kraft, Monica
    Colice, Gene L.
    Ambrose, Christopher
    Cook, William
    Hunter, Gillian
    Molfino, Eleonora A.
    Martin, Neil
    Roseti, Stephanie L.
    CHEST, 2022, 162 (04) : 11A - 12A
  • [34] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [35] EFFECT OF TEZEPELUMAB ON PATIENT-REPORTED ACTIVITY LEVELS AND SLEEP DISTURBANCE IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
    Lugogo, Njira L.
    Kraft, Monica
    Corren, Jonathan
    Bober, Magdalena
    Shenoy, Kartik V.
    Shenoy, Sonia
    Chandarana, Shradha
    Ambrose, Christopher S.
    CHEST, 2024, 166 (04) : 4651A - 4653A
  • [36] TEZEPELUMAB REDUCES MUCUS PLUGGING IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: THE PHASE 2 CASCADE STUDY
    Nordenrnark, L.
    Emson, C.
    Hellqvist, A.
    Johnston, J.
    Greberg, H.
    Griffiths, J. M.
    Newell, J. D.
    Pames, J. R.
    Colice, G.
    Brightling, C. E.
    THORAX, 2022, 77 : A32 - A32
  • [37] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Grouped by Baseline Blood Eosinophil Count and Fractional Exhaled Nitric Oxide Level: Results from the NAVIGATOR Phase 3 Study
    Corren, J.
    Bourdin, A.
    Chupp, G.
    Israel, E.
    Ambrose, C. S.
    Ackert, J. Llanos
    Kmita, K.
    Cook, B.
    Colice, G.
    Menzies-Gow, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [38] Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
    Bernstein, Jonathan A.
    Virchow, J. Christian
    Murphy, Kevin
    Maspero, Jorge Fernando
    Jacobs, Joshua
    Adir, Yochai
    Humbert, Marc
    Castro, Mario
    Marsteller, Douglas A.
    McElhattan, Jennifer
    Hickey, Lisa
    Garin, Margaret
    Vanlandingham, Rebecca
    Brusselle, Guy
    LANCET RESPIRATORY MEDICINE, 2020, 8 (05) : 461 - 474
  • [39] Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies
    Ian D. Pavord
    Christopher E. Brightling
    Stephanie Korn
    Nicole L. Martin
    Sandhia S. Ponnarambil
    Nestor A. Molfino
    Jane R. Parnes
    Christopher S. Ambrose
    Pulmonary Therapy, 2025, 11 (2) : 315 - 325
  • [40] Effect Of Tezepelumab On Rescue Medication Use And Night-Time Awakenings In Patients With Severe, Uncontrolled Asthma: Results From The NAVIGATOR Study
    Carr, Warner
    Ambrose, Chris
    Hunter, Gillian
    Ponnarambil, Sandhia
    Llanos-Ackert, Jean-Pierre
    Clarke, Nicole
    Cook, Bill
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB14 - AB14
12345